Fidel Valea appointed to leadership roles in gynecologic oncology at Northwell Health

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Fidel A. Valea was appointed system chief of gynecologic oncology at Northwell Health and director of gynecologic oncology at the Northwell Health Cancer Institute. In these roles, he will see patients in New Hyde Park and Manhattan.

Valea is joining Northwell from the Virginia Tech Carilion School of Medicine, where he was chair of obstetrics and gynecology for five years. Prior to that, Valea held several leadership roles during his 12-year tenure at Duke University School of Medicine, including vice chair of education, residency program director in obstetrics and gynecology, fellowship director in gynecologic oncology, and tenured professor. 

In his role as system chief of gynecologic oncology at Northwell Health, Valea will direct gynecologic oncology programs across the health system. Key areas of responsibility include: advancing a patient-centered approach to care, overseeing performance improvement and quality assurance studies, enhancing operational efficiencies, developing educational and academic offerings for the fellowship program and other clinical staff, and expanding gynecologic oncology research efforts.

As director of gynecologic oncology at the Northwell Health Cancer Institute, Valea will direct the development of the gynecologic oncology program throughout the health system’s central region, working with Northwell’s Divi

sion of Gynecologic Oncology.

Valea recently completed his tenure as director of Gynecologic Oncology for the American Board of Obstetrics and Gynecology and served on its board. He is one of four editors of Comprehensive Gynecology. Valea’s research interests are in pre-invasive disease of the cervix, minimally invasive surgery, and evidence-based perioperative care. 

Table of Contents

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login